Sonoma Pharmaceuticals (SNOA) Profit After Tax (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Profit After Tax of -$633000.0 for Q1 2026, down 160.0% year-over-year from $1.1 million in Q1 2025, and up 22.71% quarter-over-quarter from -$819000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Profit After Tax (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Profit After Tax history runs 17 years deep, the most recent figure standing at -$633000.0 for Q1 2026.
- In Q1 2026, Profit After Tax fell 160.0% year-over-year to -$633000.0; the TTM figure through Mar 2026 stood at -$3.2 million (down 98.46% YoY), while the FY2026 annual figure was -$2.0 million, up 40.93% from the prior year.
- Profit After Tax for Q1 2026 stood at -$633000.0, up from -$819000.0 in the prior quarter.
- The five-year high for Profit After Tax was $1.1 million in Q1 2025, with the low at -$2.7 million in Q1 2022.
- The 5-year median for Profit After Tax is -$928000.0 (2024), against an average of -$1.0 million.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax plunged 917.0% in 2022, then jumped 163.48% in 2025.
- Sonoma Pharmaceuticals' Profit After Tax stood at -$1.9 million in 2022, then soared by 70.65% to -$569000.0 in 2023, then slumped by 63.09% to -$928000.0 in 2024, then grew by 11.75% to -$819000.0 in 2025, then rose by 22.71% to -$633000.0 in 2026.
- Business Quant data shows SNOA's Profit After Tax at -$633000.0 in Q1 2026, -$819000.0 in Q4 2025, and -$534000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn | -330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -330,000.00 |
| Mar 31, 2026 | -633,000.00 |
| Dec 31, 2025 | -819,000.00 |
| Sep 30, 2025 | -534,000.00 |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -928,000.00 |
| Sep 30, 2024 | -610,000.00 |
| Jun 30, 2024 | -1.14 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -569,000.00 |
| Sep 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Mar 31, 2023 | -550,000.00 |
| Dec 31, 2022 | -1.94 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -887,000.00 |
| Mar 31, 2022 | -2.69 Mn |
| Dec 31, 2021 | -944,000.00 |
| Sep 30, 2021 | -100,000.00 |